Gluten-free diet (GFD) is the only treatment for celiac disease (CeD), requiring strict avoidance of wheat, rye, and barley. Pure oats are safe for most CeD, though cross-contamination with other sources of gluten is common. Oats are highly nutritious, yet some experts recommend delaying their introduction for six months to minimize symptoms, despite limited evidence and lack of consensus on this approach. To evaluate the impact of early versus late introduction of gluten-free oats on symptoms, nutritional status, diet quality, celiac disease activity, and quality of life in recently diagnosed celiac disease patients We conducted a pilot RCT with two arms in parallel in biopsy-proven CeD patients within 3 months of diagnosis. The study period was 6 months and involved 3 visits. Patients were randomized into one of two arms: 1) Early introduction of oats (start GF oats immediately after the diagnosis); 2) Late introduction of GF oats (remove oats from diet and introduce GF oats at 6 months). Participants in both arms met a registered dietician for GFD education. They completed questionnaires assessing dietary intake, oats intake, gastrointestinal symptoms (GSRS), Celiac Symptom Index (CSI) for symptoms related to celiac disease, and the Celiac-related quality of life (CeD-QoL) at baseline, 3, and 6 months after. Clinical activity related to CeD was defined based on an established cut-off of > 30 in CSI. From June 2023 to June 2025, 559 patients visited the McMaster University Medical Centre’s Celiac Clinic, of whom 85 met eligibility criteria. Of them, 37 consented, with 6 dropping out before randomization, and 31 were randomized. Of these, 21 patients completed the study (n = 11 ‘early’ and n = 10 ‘late’ oats), and 10 visits are ongoing. The recruitment rate averaged two patients per month, with retention rates of 67.7%. Preliminary analysis of those who completed the study showed no differences in baseline demographics between groups. After 6 months, there were no differences in the overall celiac-related symptoms between groups (CSI >30 early vs late= 22.5% vs 25.0%). The early oats group reported less gastrointestinal symptoms compared with late oats group [Median GSRS early vs late = 23.0 (11) vs 28.5 (37)]. No differences in QoL scores were observed in those randomized to early oats compared with late oats [Median CeD- QOL early vs late= 44.0 (24) vs 45.5 (49)]. Our preliminary analysis suggests that incorporating gluten-free oats into a gluten-free diet may alleviate gastrointestinal symptoms in celiac patients, challenging current dietary recommendations and highlighting the need for further clinical investigation. Regional Medical Associates (RMA) Scholarship Fund (McMaster University), J. A. Campbell Research Grant (Celiac Canada)
Prior surveys of those with celiac disease (CeD) in Canada have revealed changes in the most commonly experienced symptoms, with a growing recognition of extraintestinal manifestations of disease. Accordingly, it is worthwhile to understand if and how patient factors are associated with the severity and types of symptoms as well as their resolution after diagnosis. Identify characteristics associated with greater symptoms among Canadians living with CeD. An online survey was conducted in 2022, with information collected on domains such as demographics, symptoms, diagnosis, and management of the gluten-free diet (GFD). Cumulative link models were fit to estimate the association between respondent factors (gender, race/ethnicity, urban/rural status, income, education) with the number of symptoms experienced prior to diagnosis across three categories: gastrointestinal, extraintestinal, and psychological. Models were also fit for the likelihood of recovering from the three most common symptoms per category after initiation of the GFD. Models were adjusted for age, time since diagnosis, and comorbidities. Among 7491 respondents, two-thirds (66%) reported being diagnosed by biopsy, with the remainder diagnosed by serology only or symptoms. Across all three symptom categories, there were increased odds of having more symptoms among females (F) compared to males (p < 0.001), whites compared to racialized persons (p < 0.05), rural settings (p < 0.001), lower income brackets (p < 0.001), and less than high school education compared to other education groups (p < 0.05). Males were more likely to recover from bloating (p < 0.001) and abdominal pain (p=0.040) than females, and an increasing likelihood of recovery for bloating, abdominal pain, and gas was associated with higher levels of income. Males were more likely than females to recover from weakness/tiredness (p = 0.002) and iron deficiency (p=0.002) than females as well as those living in urban areas or cities compared to those in rural areas (p<0.001). Similar trends were observed across income; there were no differences in likelihood of recovering from headaches/migraines between any respondent factor. Recovering from brain fog was higher in more urban areas (p=0.013); this increase was also observed as income levels increased (p<0.001). Males were more likely than females to recover from anxiety (p=0.009). There is notable variation in the number of symptoms experienced across demographic and socioeconomic characteristics. Additionally, these patient-level factors may be associated with greater difficulties in symptom recovery; further efforts should focus on providing support for those at increased risk of symptom-related burden such as low-income individuals. Celiac Canada
Background and objectives The variability in gluten in non-gluten-containing grains (NGCG) processed using two preparation schemes was evaluated with the aim of minimizing effects of sample heterogeneity on gluten determined by enzyme linked immunosorbent assay (ELISA). The relationship between gluten concentration as determined by ELISA and visually assessed contamination of NGCG with wheat, durum, barley, and rye was investigated. Findings Conclusions Low variability between duplicate aliquots taken from test portions (0-30.6% relative standard deviation [RSD]) demonstrated the ELISA itself was precise. In the first scheme, variability among test portions ranged from 1% to 143% RSD, with only half in the range of 1-50%. Using scheme 2, variability in gluten among test portions ranged from 1% to 85% RSD, with more than three quarters in the range of 1-50%. High lipid content hemp seed was a particular challenge to grind, and this was reflected in higher variability in gluten results between test portions (mean RSD = 61%). Subsampling ground samples using rotary sample division and the use of a 1-g test portion in scheme 2 decreased the variability of gluten results for most samples. At concentrations relevant to existing thresholds of gluten contamination (e.g. 20 mg/kg), there was no relationship between gluten concentration in NGCG and cereal contamination as determined by visual inspection. Significance and novelty This study provides guidance on how to improve the analysis of gluten contamination in NGCG by ELISA and describes the absence of a relationship between ELISA-determined gluten and the visual assessment of contamination in NGCG.
OBJECTIVEStrict adherence to a gluten-free diet is the only treatment for coeliac disease. The gluten-free diet is complex, costly and impacts on all activities involving food, making it difficult to maintain for a lifetime. The purpose of this cross-sectional study was to evaluate the difficulties experienced, the strategies used and the emotional impact of following a gluten-free diet among Canadians with coeliac disease.METHODSA questionnaire was mailed to all members (n = 10 693) of both the Canadian Celiac Association and the Fondation québécoise de la maladie cœliaque in 2008.RESULTSThe overall response rate was 72%. Results are presented for the 5912 respondents (≥18 years) reporting biopsy-confirmed coeliac disease and/or dermatitis herpetiformis. Two-thirds never intentionally consumed gluten. Women reported significantly greater emotional responses to a gluten-free diet but, with time, were more accepting of it than men. Difficulties and negative emotions were experienced less frequently by those on the diet for >5 years, although food labelling and eating away from home remained very problematic. Frustration and isolation because of the diet were the most common negative emotions experienced.CONCLUSIONSThe present study quantifies the difficulties experienced, the strategies used and the emotional impact of following a gluten-free diet. It highlights the need to improve the training and education of dietitians, other health providers and the food service industry workers about coeliac disease and a gluten-free diet, with the aim of better helping individuals improve their adherence to a gluten-free diet and their quality of life.
BACKGROUND:Celiac disease can present with mild or nongastrointestinal symptoms, and may escape timely recognition. The treatment of celiac disease involves a gluten-free diet, which is complex and challenging.OBJECTIVE:To evaluate clinical features and symptom recovery on a gluten-free diet in a Canadian adult celiac population.METHODS:All adult members (n=10,693) of the two national celiac support organizations, the Canadian Celiac Association and Fondation québécoise de la maladie coeliaque, were surveyed using a questionnaire.RESULTS:A total of 5912 individuals (≥18 years of age) with biopsy-confirmed celiac disease and⁄or dermatitis herpetiformis completed the survey. The female to male ratio was 3:1, and mean (± SD) age at diagnosis was 45.2 ± 16.4 years. Mean time to diagnosis after onset of symptoms was 12.0 ± 14.4 years. Abdominal pain and bloating (84.9%), extreme weakness⁄tiredness (74.2%), diarrhea (71.7%) and anemia (67.8%) were the most commonly reported symptoms at the time of diagnosis. Many respondents continued to experience symptoms after being on a gluten-free diet for >5 years. Sex differences were reported in clinical features before diagnosis, recovery after being on gluten-free diet and perceived quality of life, with women experiencing more difficulties than men.CONCLUSIONS:Delays in diagnosis of celiac disease in Canada remain unacceptably long despite wider availability of serological screening tests. Many patients report continuing symptoms despite adhering to a gluten-free diet for >5 years, with women experiencing more symptoms and a lower recovery rate than men. Awareness of celiac disease needs improvement, and follow-up with a physician and a dietitian is essential for all patients with celiac disease.